Latest filing published 03 Mar 2025 for Phathom Pharmaceuticals, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +19.7%Entry US$8.75 · Close at T+365 US$10.47
- +33.4%Entry US$9.95 · Close at T+365 US$13.27
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Azmi Nabulsi: trading record in brief
Azmi Nabulsi is a declared insider of Phathom Pharmaceuticals, Inc. (senior executive), with filings sourced from SEC (Form 4). In total, 44 filings cover trades dated from 4 January 2020 to 27 February 2025.
The open-market side counts 2 purchases for €232k alongside 32 sales for €3.5M. Sales outweigh purchases by €3.3M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 8 share grants. Since January 2025: no purchases and 1 sale on the market.
Most recently, on 3 March 2025, the filings show a share grant in Phathom Pharmaceuticals, Inc. The last insider purchase was made public on 11 April 2023, 1,308 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Azmi Nabulsi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 79,200 shares0Common StockSEC:0000950170-25-031034:0
- 7,886 shares@ US$6.58859.2% of flowCommon StockSEC:0000950170-25-008353:0
- 1,118 shares@ US$8.001.6% of flowCommon StockSEC:0000950170-24-139063:0
- 10,901 shares@ US$11.7221.6% of flowCommon StockSEC:0000950170-24-084186:0
- 7,500 shares0Common StoockSEC:0000950170-24-067539:0
- 32,500 shares0Common StockSEC:0001209191-23-054352:0
- 110,000 sharesCommon StockSEC:0001209191-23-042453:0
- 10,000 shares@ US$8.2613.9% of flowCommon StockSEC:0001209191-23-023989:0Canonical exit: 10 Jul 2023 (T+90)
- 45,000 shares0Common StockSEC:0001209191-23-004339:0
- 7,500 shares0Common StockSEC:0001209191-22-048471:0
- 12,000 shares0Common StockSEC:0001209191-22-031090:0
- 20,000 shares@ US$8.164428.8% of flowCommon StockSEC:0001209191-22-029453:0Canonical exit: 14 Aug 2022 (T+90)
- 19,500 shares0Common StockSEC:0001209191-22-004496:0
- 5,753 shares@ US$38.595.5% of flowCommon StockSEC:0001209191-21-030141:1
- 1,968 shares@ US$36.151.8% of flowCommon StockSEC:0001209191-21-030141:2
- 1,400 shares@ US$37.091.3% of flowCommon StockSEC:0001209191-21-030141:3
- 1,089 shares@ US$37.861.0% of flowCommon StockSEC:0001209191-21-030141:4
- 4,290 shares@ US$37.846124.8% of flowCommon StockSEC:0001209191-21-030141:0
- 3,405 shares@ US$37.283.2% of flowCommon StockSEC:0001209191-21-025456:0
- 1,742 shares@ US$38.141.7% of flowCommon StockSEC:0001209191-21-025456:1
- 4,252 shares@ US$35.663.8% of flowCommon StockSEC:0001209191-21-025456:2
- 4,316 shares@ US$36.374.0% of flowCommon StockSEC:0001209191-21-025456:3
- 785 shares@ US$37.110.7% of flowCommon StockSEC:0001209191-21-025456:4
- 3,825 shares@ US$45.774.3% of flowCommon StockSEC:0001209191-21-017484:0
- 1,548 shares@ US$46.051.8% of flowCommon StockSEC:0001209191-21-017484:1
25 of 44 declarations
